S. C. Remick

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.

Bruce J. Dezube, Jamie H. Von Roenn, Jeanne Holden‐Wiltse et al. · Journal of Clinical Oncology · 1998 · 130 citations

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole.

D L Trump, Merrill J. Egorin, Alan Forrest et al. · Journal of Clinical Oncology · 1991 · 92 citations

Medicine, Pharmacokinetics, Pharmacology +14

Comparison of Child-Pugh (CP) criteria and NCI organ dysfunction working group (NCI-ODWG) criteria for hepatic dysfunction (HD): Implications for chemotherapy dosing

Hiteshkumar D Patel, Merrill J. Egorin, S. C. Remick et al. · Journal of Clinical Oncology · 2004 · 59 citations

Medicine, Hematology, Pharmacotherapy +17

Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma (ATC)

Matthew M. Cooney, P. Savvides, Sanjiv S. Agarwala et al. · Journal of Clinical Oncology · 2006 · 54 citations

Medicine, Oncology, Pharmacology +9

A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial.

Julie Ann Sosa, Rossella Elisei, Barbara Jarząb et al. · Journal of Clinical Oncology · 2011 · 40 citations

Medicine, Oncology, Pharmacology +12